Artificial intelligence is changing how medical information can be reviewed and interpreted. Developers now have opportunities to create tools that help clinicians recognize patterns, evaluate symptoms, and make informed decisions. Andrew Ting believes developers must consider patient safety, medical evidence, privacy, and practical clinical use from the beginning.
Start With a Clearly Defined Medical Purpose
Every diagnostic tool should begin with a specific clinical problem rather than an interesting technology looking for an application. Developers need to understand who will use the system, which patients it will serve, and what decisions it is supposed to support. Defining those details early can keep a project focused on an actual medical need.
The intended purpose also affects how developers design and test the system. Software that helps identify a possible skin condition presents different risks from technology intended to detect a life threatening cardiac problem. Developers should understand the consequences of both incorrect results and conditions the system fails to recognize.
Input from physicians can help technical teams understand situations that may not be obvious from a dataset. Clinical decisions often involve symptoms, medical history, test results, medications, and observations that are difficult to reduce to a single variable. Working with clinicians throughout development can help ensure the technology reflects how healthcare decisions are actually made.
Pay Close Attention to Training Data
An AI system learns from the information developers provide, making the quality of training data extremely important. Large datasets are not automatically useful if records contain errors, inconsistent labels, or information that does not represent the intended patient population. Developers should examine where their data originated and how accurately it reflects clinical reality.
Representation deserves particular attention because patients can differ considerably in age, sex, health history, and other characteristics. A model trained heavily on one patient population may perform differently when introduced into another hospital or community. Testing should therefore look beyond overall accuracy and examine performance across relevant patient groups.
Developers should also document how they selected, prepared, labeled, and reviewed information. That record can make it easier to investigate unexpected results and understand weaknesses that appear during testing. Dr Andrew Ting encourages careful consideration of the evidence behind a medical tool rather than relying solely on impressive performance numbers.
Understand That Accuracy Has Several Meanings
An impressive accuracy rate does not necessarily mean a diagnostic tool is ready for clinical use. Developers also need to look at how often the system misses a condition and how frequently it flags a problem that is not actually there. Which numbers matter most will depend on the condition the tool is designed to detect.
Missing a serious illness can have very different consequences from incorrectly suggesting that a patient may have one. A missed diagnosis could delay treatment, while an incorrect warning might lead to extra tests, unnecessary procedures, and considerable worry for the patient. Clinicians can help developers decide how these risks should be weighed for a particular medical setting.
Testing also needs to reflect what the tool will encounter outside a controlled research environment. Patient records may be incomplete, images can vary in quality, and hospitals may use different equipment or methods for gathering information. Putting the system through realistic situations can uncover problems that might never appear when it is tested only with carefully prepared data.
Build Privacy Into the Product
Diagnostic systems may process some of the most sensitive information a person has. Medical histories, laboratory results, images, genetic information, and other patient records require careful handling throughout development and operation. Privacy cannot simply be added after the product has already been designed.
It is also worth asking whether every piece of information being collected is actually necessary. People should only have access to patient records when they need them for their work, and sensitive information should be protected while it is stored or transferred. Companies should also decide how long records need to be kept rather than allowing old patient data to remain in their systems indefinitely.
Patient information does not always stay within the company that created the diagnostic tool. Cloud hosting services, analytics platforms, and other outside vendors may handle some of that data as part of their work. Legal and development teams should know which vendors receive patient information, why they receive it, and how they are expected to keep it secure.
Keep Clinicians Involved in Decisions
AI diagnostic tools should be designed around the people who will actually use them. Physicians need information that is understandable, relevant, and presented at a useful point in their workflow. An alert that arrives too late or provides little explanation may offer limited value regardless of the technology behind it.
Developers also need to consider how physicians might respond to an automated recommendation. Doctors should have a clear idea of what the system does well and where it may be less reliable. This can help prevent an AI generated result from being accepted automatically when other clinical information suggests something different.
Doctors should still have a voice once the technology is being used with patients. They may notice confusing results, awkward steps in their workflow, or situations the development team did not encounter during testing. Making it simple for them to report these problems gives developers useful information for improving the tool over time.
Prepare for Regulation and Ongoing Monitoring
Medical software may face regulatory requirements depending on its purpose, functions, and level of risk. Developers should investigate those requirements early because they can influence testing, documentation, quality controls, and product design. Waiting until launch approaches can make necessary changes considerably harder.
The work also continues after a diagnostic system enters the market. Changes in patient populations, clinical practices, software integrations, or incoming data can affect how a model performs over time. Regular monitoring can help companies identify unexpected changes before they create widespread problems.
Updates should receive careful review as well. Altering a model, adding new data, or changing an algorithm may improve performance, but it can also introduce new weaknesses. Companies need a structured process for evaluating changes and documenting what was modified.
Final Thoughts
Building a useful AI diagnostic tool requires more than creating an algorithm that produces convincing results. Andrew Ting encourages developers to consider clinical purpose, reliable data, patient privacy, realistic testing, and physician involvement throughout the process. Careful planning can reveal problems that technical performance measurements alone may overlook.
